BioCentury
ARTICLE | Financial News

Naurex closes $38 million B round

December 18, 2012 2:33 AM UTC

Naurex Inc. (Evanston, Ill.) raised $38 million in a series B round led by new investor Baxter Ventures. New investor Savitr Capital joined existing investors Adams Street Partners; Latterell Venture Partners; Genesys Capital; PathoCapital; Druid Bioventures, Northwestern University; and other private investors. Takeda Ventures; H. Lundbeck A/S (CSE:LUN) and Shire plc (LSE:SHP; NASDAQ:SHPG) also participated. Baxter's Norbert Riedel and Ian Ferrier, an advisor to Savitr, will join Naurex's board. ...